Company Registration No. 14901052 (England and Wales)
SINAPI BIOMEDICAL UK LTD
Unaudited accounts
for the period from 29 May 2023 to 31 May 2024
SINAPI BIOMEDICAL UK LTD
Unaudited accounts
Contents
SINAPI BIOMEDICAL UK LTD
Company Information
for the period from 29 May 2023 to 31 May 2024
Company Number
14901052 (England and Wales)
Registered Office
124 CITY ROAD
LONDON
EC1V 2NX
UNITED KINGDOM
Accountants
Sleek Accounting Ltd
205 Regent Street
4th Floor
London
W1B 4HB
SINAPI BIOMEDICAL UK LTD
Statement of financial position
as at 31 May 2024
Cash at bank and in hand
8,943
Creditors: amounts falling due within one year
(8,943)
Called up share capital
100
For the period ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 8 January 2025 and were signed on its behalf by
Dirk De Villiers
Director
Company Registration No. 14901052
SINAPI BIOMEDICAL UK LTD
Notes to the Accounts
for the period from 29 May 2023 to 31 May 2024
SINAPI BIOMEDICAL UK LTD is a private company, limited by shares, registered in England and Wales, registration number 14901052. The registered office is 124 CITY ROAD, LONDON, EC1V 2NX, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Amounts falling due within one year
5
Creditors: amounts falling due within one year
2024
Amounts owed to group undertakings and other participating interests
8,943
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
7
Transactions with related parties
Sinapi Holdings Proprietary Limited
The company is related to Sinapi Biomedical UK Ltd by virtue of common directors and also holding 100% shareholding in the company.
Sinapi Biomedical (Pty) Ltd
The Company is related to Sinapi Biomedical UK Ltd by virtue of common directors. The amount owed to Sinapi Biomedical (Pty) Ltd at the balance sheet date was £8,943.
8
Average number of employees
During the period the average number of employees was 0.